Expand Your Research Potential Learn about Accelevir Diagnostics' quantitative assays for protein analysis, including #HIV-1 P24 and LAg-avidity. Accelevir's offerings can expand to various human, rodent, NHP, and pig protein targets. #QuantitativeAssays #ProteinAnalysis #InfectiousDiseaseResearch ➡️ Find out more at https://lnkd.in/eha7qVYP
About us
Accelevir Diagnostics is a growing Maryland biotechnology company creating innovative assays for ultra-rare analytes in infectious disease and beyond. With expertise spanning virology, immunology, genomics and cell and gene therapy, our team develops, scales, and commercializes complex assay workflows to support our biopharma partners from basic research through clinical trials. We are currently focused on advancing new assays for persistent HIV-1 and other clinically important viral infections. To date, we have received over $15M in federal, state and private funding to advance our assays. We are actively working with leading academic and bio-pharma groups to provide our assays in support of translational research and early-stage clinical trials aimed at developing game-changing therapeutics with the potential to cure chronic viral infections.
- Website
-
http://www.accelevirdx.com
External link for Accelevir Diagnostics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Baltimore, Maryland
- Type
- Privately Held
- Specialties
- HIV/AIDS, Virology, Genomics, Immunology, Digital PCR, CRO Assay Services, and Assay Validation/Verification
Locations
-
Primary
Get directions
701 E Pratt St
Baltimore, Maryland 21202, US
Employees at Accelevir Diagnostics
-
Greg Laird
Virologist and Biotech Entrepreneur
-
Hannah MacLeod
Senior scientist at Accelevir Diagnostics specializing in novel assay development for advanced viral diagnostics.
-
Bobbi Urban
MB (ASCP)CM | LSS Green Belt | Molecular Diagnostics | Clinical Operations | Laboratory Management | Regulatory Compliance | Pinball Enthusiast
-
Daniel Grun
Team Lead - Immunology Services
Updates
-
💡 Conserved patterns, global solutions At the heart of #HIV-1 cure research is the ability to distinguish between intact and defective proviruses. Dr. Hannah MacLeod’s latest work, presented at #CROI2024, highlights AccelevirDx’s advances in #sequencing technology, showing consistent proviral landscapes across Group M. This research supports the global application of IPDA® Version 2, driving us closer to a unified HIV-1 cure effort. 📍 Learn more about her cutting-edge findings https://bit.ly/3TghsBT
-
-
📅 Join us at "HIV in 2024: Progress, Problems, and Prospects,” hosted by Hood College in partnership with Frederick National Laboratory for Cancer Research, September 23-25 in Frederick, Maryland. Explore the latest in HIV/AIDS research with esteemed experts. Topics include next-gen vaccine design and delivery approaches, molecular aspects of the HIV reservoir, CNS infections with HIV and more: hood.ws/hivs-2024 #HIVS2024
-
-
Accelevir Diagnostics reposted this
Exciting to see Albine Martin representing Accelevir Diagnostics on the #BHCR entrepreneur's panel today! BioHealth Innovation, Inc. #entrepreneurs #biohealthweek #maryland
-
-
Together, Accelevir Diagnostics and Noble Life Sciences Inc Sciences are attending the 10th Annual BioHealth Capital Region Forum this week! Albine Martin, Greg Laird, Kenneth Carter, Denny Snyder, Yongping Chen (CRO, Oncology, Infectious Diseases, Cell & Gene Therapy), and Haimi Shiferaw will be attending the Forum this week and the Crab Trap Pitch Competition on the 18th. 🦀 We are proud to help sponsor this year's Crab Trap Competition, and we look forward to hearing the finalist's pitch today. We're excited to see who will win this year's event! Learn more about this event: https://lnkd.in/e4UP-R3u BioHealth Innovation, Inc. BioHealth Capital Region #biohealth #biotech #maryland #lifesciences #biopharma #BHCR #crabtrap #biotechindustry
-
🧬 Can sequencing revolutionize #HIV-1 cure research? Dr. Hannah MacLeod’s poster at #CROI2024 unveils new discoveries in HIV-1 provirus analysis across major Group M subtypes. Utilizing AccelevirDx’s innovative single-genome sequencing assay, the study demonstrates critical conserved patterns in proviral defects—findings that could shape the future of global HIV-1 cure strategies. 🚀 📊 Dive deeper into the research and how it supports the development of IPDA® Version 2: https://bit.ly/3TghsBT
-
-
Join Us at the BHI Crab Trap Competition! Exciting news! 🚀 Accelevir and Noble Life Sciences will be at the BHI Crab Trap Competition this week, showcasing our cutting-edge work in infectious diseases, oncology, and cell & gene therapy. Don't miss this chance to learn more about our innovative research and how we're driving forward the future of therapeutics. Looking forward to connecting with you there! #Innovation #Biotech #CrabTrap #BHI #Accelevir #NobleLifeSciences #biohealthinnovation
-
-
🔬 How can we better understand the global HIV-1 reservoir? At #CROI2024 in Denver, Senior Scientist Dr. Hannah MacLeod presented work revealing conserved #HIV-1 reservoir landscape composition across Group M. Using AccelevirDx’s high-throughput sequencing assay, her research highlights critical insights into HIV-1 proviral defects outside Subtype B, which is key for advancing cure research globally. 🌍 👉 Discover the full findings and the development of IPDA® Version 2: https://bit.ly/3TghsBT
-
-
🌐 Meet us at #ASGCT24 booth 2172! Explore how Accelevir and Noble Life Sciences are redefining preclinical to clinical transitions. 🚀 Don't forget to enter our iPad raffle while you’re there! 🎟️ #cellandgene #ASGCT #baltimore
-
Excited for #ASGCT24? Join us at booth 2172 to meet the powerhouse collaboration between Accelevir and Noble Life Sciences! Our mastermind group brings together cutting-edge expertise in cell and gene therapy and life sciences. Learn about our innovative joint services and enter to win an iPad! See you there for a glimpse into the future of biotech! #baltimore #ASGCT24 #cellandgene
-